The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org.
Immunization is widely acknowledged as the most cost-effective and focused disease intervention, and yet each year an estimated three million children under the age of five lose their lives to preventable illnesses. A majority of these deaths occur in low-income and middle-income countries, where poverty and lack of affordability prevent access to life-saving vaccines.
To ensure all children have access to effective and affordable immunization, addressing the main causes of child mortality, CHAI’s Vaccines Markets Team works with vaccine manufacturers, Gavi and other global stakeholders to accelerate time to market of key vaccines and negotiate lower vaccine prices for existing and future vaccines. In doing this, CHAI is applying the techniques it has used successfully to improve access to HIV/AIDS and malaria treatment: improving market demand transparency for individual suppliers, and working closely with these suppliers to optimize their commercial, costing and pricing strategies in low and middle income markets, to keep prices in these markets affordable, yet commercially sustainable.
In addition to this supplier-focused pricing work, CHAI’s vaccines markets team, jointly with its global vaccine delivery team and country teams, is working with a number of country governments to help prepare their vaccine procurement systems and processes for Gavi transition. The goal of this work is to ensure that countries that no longer receive Gavi support can make well-informed decisions on vaccine procurement and access the lowest possible prices for their preferred vaccines.
Since 2011, CHAI has worked in this field and has negotiated price reductions for major vaccines. For example, earlier work has resulted in a reduction in the price of rotavirus vaccine by two-thirds, resulting in savings of over USD$600M for global donors and governments over 5 years and a reduction in the price of pentavalent vaccine by 45%, generating savings of $150M over 4 years. Some selected news articles about CHAI’s work on access in vaccines and other areas are listed here:
To support this work, CHAI is looking to hire an Associate, Global Markets - Vaccines. As part of the global Vaccines Markets team, the Associate is expected to support the achievement of affordable yet sustainable global vaccine prices and supply.
We are seeking a highly motivated individual with outstanding analytical ability, communication skills, and academic credentials. The successful candidate will adhere to the core CHAI values of resourcefulness, entrepreneurialism, flexibility, independence, humility, and work ethic. The responsibilities of the Associate, Global Markets - Vaccines include but are not limited to the following: